Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 1.00 |
| ▸ | CA6 | P23280 | 5/20 | 1.00 |
| ▸ | CA7 | P43166 | 5/20 | 1.00 |
| ▸ | CA9 | Q16790 | 5/20 | 1.00 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 1.00 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 1.00 |
| ▸ | CA2 | P00918 | 4/20 | 1.00 |
| ▸ | CA4 | P22748 | 4/20 | 1.00 |
| ▸ | CA5A | P35218 | 4/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 3/20 | 1.00 |
| ▸ | F13A1 | P00488 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | THPO | P40225 | 2/20 | 1.00 |
| ▸ | CASP2 | P42575 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | RECQL | P46063 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
| ▸ | CA3 | P07451 | 3/20 | 0.93 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Spermine SCHEMBL30446193 | 1.00 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| Spermine SCHEMBL8514287 | 1.00 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| Spermine SCHEMBL14965 | 1.00 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| SCHEMBL12002491 | 0.96 | CA12 (0.93) | CA12CA6CA7CA9CA14 | |
| Spermine SCHEMBL431884 | 0.96 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| Spermine SCHEMBL1167355 | 0.96 | UBE2N (1.00) | CA12CA6CA7CA9CA14 | |
| Spermine SCHEMBL6328887 | 0.96 | CA12 (0.93) | CA12CA6CA7CA9CA14 | |
| Spermine SCHEMBL1273895 | 0.96 | CA12 (0.93) | CA12CA6CA7CA9CA14 | |
| SCHEMBL3159000 | 0.96 | CA12 (0.93) | CA12CA6CA7CA9CA14 | |
| SCHEMBL995526 | 0.96 | CA12 (0.93) | CA12CA6CA7CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106635953-B | Serum-free and protein-free cell culture medium | 昆明润什生物科技有限公司 | 2021-02-19 | — | — | CN | claimed |
| EP-2647656-A2 | Bioresorbable and biocompatible thermoplastic elastomer having a shape memory, particularly for biomedical applications and a process for their preparation | Centrum Materialów Polimerowych i Weglowych PAN (PL) | 2013-10-09 | — | — | EP | claimed |
| WO-2018134329-A1 | METABOLIC BIOMARKER SET FOR ASSESSING OVARIAN CANCER | BIOCRATES LIFE SCIENCES AG (AT) | 2018-07-26 | — | — | WO | disclosed |
| CN-105168046-B | A kind of hair growth composition containing plant extracts | 珀莱雅化妆品股份有限公司 | 2018-01-30 | — | — | CN | disclosed |
| EP-3193852-A1 | NMDA RECEPTOR ANTAGONISTS FOR TREATING GAUCHER DISEASE | Yeda Research and Development Co., Ltd. (IL) | 2017-07-26 | — | — | EP | disclosed |
| EP-3191845-A1 | BIOMARKERS FOR ASSESSING BREAST CANCER | IDCGS Clínica de Diagnósticos Médicos Ltda (BR) | 2017-07-19 | — | — | EP | disclosed |
| EP-3126841-A1 | BIOMARKERS FOR ASSESSING HIV | IDCGS clinica de Diagnosticos Medicos (BR) | 2017-02-08 | — | — | EP | disclosed |
| EP-2427773-B1 | METHOD OF DIAGNOSING ASPHYXIA | INFANDX AG (DE) | 2016-07-06 | — | — | EP | disclosed |
| WO-2016038616-A1 | NMDA RECEPTOR ANTAGONISTS FOR TREATING GAUCHER DISEASE | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2016-03-17 | — | — | WO | disclosed |
| WO-2016038157-A1 | BIOMARKERS FOR ASSESSING BREAST CANCER | IDCGS CLÍNICA DE DIAGNÓSTICOS MÉDICOS LTDA (BR) | 2016-03-17 | — | — | WO | disclosed |
| CN-105168046-A | Hair growth promoting composition containing plant extracts | PROYA COSMETICS CO LTD | 2015-12-23 | — | — | CN | disclosed |
| WO-2011012553-A1 | METHOD FOR PREDICTING THE LIKELIHOOD OF AN ONSET OF AN INFLAMMATION ASSOCIATED ORGAN FAILURE | BIOCRATES LIFE SCIENCES AG (AT) | 2011-02-03 | — | — | WO | disclosed |
| WO-2010128054-A1 | METHOD OF DIAGNOSING ASPHYXIA | BIOCRATES LIFE SCIENCES AG (AT) | 2010-11-11 | — | — | WO | disclosed |
| US-20100063322-A1 | NOVEL POLYAMINE DERIVATIVES | NIHON UNIVERSITY (JP) | 2010-03-11 | — | — | US | disclosed |
| EP-2096106-A1 | NOVEL POLYAMINE DERIVATIVES | Nihon University (JP) | 2009-09-02 | — | — | EP | disclosed |
| WO-2008147214-A1 | FOOD ARTICLE WITH IMPROVED SHELF LIFE | NOFIMA AKVAFORSK-FISKERIFORSKNING AS (NO) | 2008-12-04 | — | — | WO | disclosed |
| US-20070129505-A1 | Bioabsorbable compounds and compositions containing them | TYCO HEALTHCARE GROUP LP | 2007-06-07 | — | — | US | disclosed |
| CN-1349402-A | Encapsulation of bioactive complexes in liposomes | LIPOSOME CO INC (US) | 2002-05-15 | — | — | CN | disclosed |
| US-4373026-A | FERMENTATION OF PENICILLIUM | AMANO PHARMACEUTICAL CO., LTD. (JP) | 1983-02-08 | — | — | US | disclosed |
| US-4371621-A | OXIDATION OF SPERMINE AND SPERMIDINE | AMANO PHARMACEUTICAL CO., LTD. (JP) | 1983-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100063322-A1 | NOVEL POLYAMINE DERIVATIVES | SRM, SMS, H1-3 | CA12 2932/4885CA6 2977/4885CA7 2247/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.